Oxaliplatin doublets in non-small cell lung cancer: a literature review.
about
[A randomized clinical trial on the clinical efficacy and toxicities of single-agent paclitaxel liposome versus paclitaxel liposome plus oxaliplatin as first-line chemotherapy for advanced non-small cell lung cancer in elderly patients].Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study.Phthalate exposure promotes chemotherapeutic drug resistance in colon cancer cells.
P2860
Oxaliplatin doublets in non-small cell lung cancer: a literature review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oxaliplatin doublets in non-small cell lung cancer: a literature review.
@en
Oxaliplatin doublets in non-small cell lung cancer: a literature review.
@nl
type
label
Oxaliplatin doublets in non-small cell lung cancer: a literature review.
@en
Oxaliplatin doublets in non-small cell lung cancer: a literature review.
@nl
prefLabel
Oxaliplatin doublets in non-small cell lung cancer: a literature review.
@en
Oxaliplatin doublets in non-small cell lung cancer: a literature review.
@nl
P2093
P1433
P1476
Oxaliplatin doublets in non-small cell lung cancer: a literature review.
@en
P2093
Alberto Fusi
Diego Cortinovis
Emilio Bajetta
Nicoletta Zilembo
Paolo Bidoli
P304
P356
10.1016/J.LUNGCAN.2008.03.005
P577
2008-04-25T00:00:00Z